doi:10.1016/j.virs.2023.07.005

[1]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
[2]
Yuming Li, Yanhong Tang, Xiaoqian Wang, Airu Zhu, Dongdong Liu, Yiyun He, Hu Guo, Jie Zheng, Xinzhuo Liu, Fengyu Chi, Yanqun Wang, Zhen Zhuang, Zhaoyong Zhang, Donglan Liu, Zhao Chen, Fang Li, Wei Ran, Kuai Yu, Dong Wang, Liyan Wen, Jianfen Zhuo, Yanjun Zhang, Yin Xi, Jingxian Zhao, Jincun Zhao, Jing Sun, 2024: Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model, Virologica Sinica, 39, 414-421. doi: 10.1016/j.virs.2024.04.005
[3]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
[4]
Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Hua-Jun Zhang, Yi-Wu Zhou, Ge Gao, Ying Chen, Yun Peng, Mei-Qin Liu, Ya-Nan Zhang, Juan Min, Jia Lu, Xiao-Xiao Gao, Jing Guo, Cheng Peng, Xu-Rui Shen, Qian Li, Kai Zhao, Lian Yang, Xin Wan, Bo Zhang, Wen-Hui Wang, Jia Wu, Peng Zhou, Xing-Lou Yang, Shuo Shen, Chao Shan, Zhi-Ming Yuan, Zheng-Li Shi, 2021: Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates, Virologica Sinica, 36, 879-889. doi: 10.1007/s12250-021-00376-w
[5]
Kangyin Li, Qi Liu, Yan Wu, Bihao Wu, Shaohong Chen, Xinghai Zhang, Xiaoying Jia, Rui Gong, Yucai Peng, Huajun Zhang, Sandra Chiu, 2024: A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1, Virologica Sinica, 39, 833-835. doi: 10.1016/j.virs.2024.08.003
[6]
Yanjun Zhang, Haiyan Mao, Ju Li, Jianhua Li, Chen Huang, Jiaxuan Li, Minglei Chu, Fengbo Xue, Linhui Wang, Zhongbiao Fang, Zhen Wang, Jinan Wu, Keda Chen, 2023: Delta (B.1.617.2) inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques, Virologica Sinica, 38, 627-630. doi: 10.1016/j.virs.2023.05.009
[7]
Fan Shen, Chun Liang, Cui-Xian Yang, Ying Lu, An-Qi Li, Ying Duan, Mi Zhang, Ren-Rong Tian, Xing-Qi Dong, Yong-Tang Zheng, Wei Pang, 2024: SARS-CoV-2 breakthrough infections following inactivated vaccine vaccination induce few neutralizing antibodies against the currently emerging Omicron XBB variants, Virologica Sinica, 39, 173-176. doi: 10.1016/j.virs.2023.11.007
[8]
Chuan-hai ZHANG, Xin-jian LIU, Yi-fei WANG, Jia-hai LU, Huan-ying ZHENG, Sheng XIONG, Mei-ying ZHANG, Qiu-ying LIU, 2007: Immune Responses and Histopathological Changes in Rabbits Immunized with Inactivated SARS Coronavirus*, Virologica Sinica, 22, 360-365.
[9]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
[10]
Wei Yang, Songliu Yang, Lei Wang, Yuxin Zhou, Yu Xin, Hongxu Li, Wenjing Mu, Qi Wu, Lei Xu, Mingyan Zhao, Changsong Wang, Kaijiang Yu, 2022: Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China, Virologica Sinica, 37, 704-715. doi: 10.1016/j.virs.2022.07.014
[11]
Jingyi Yang, Ejuan Zhang, Maohua Zhong, Qingyu Yang, Ke Hong, Ting Shu, Dihan Zhou, Jie Xiang, Jianbo Xia, Xi Zhou, Dingyu Zhang, Chaolin Huang, You Shang, Huimin Yan, 2020: Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection, Virologica Sinica, 35, 838-841. doi: 10.1007/s12250-020-00277-4
[12]
Haiyan Shen, Yanxing Cai, Huan Zhang, Jie Wu, Lin Ye, Penghui Yang, Xiaojun Lin, Shibo Jiang, Ming Liao, 2021: Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19, Virologica Sinica, 36, 1080-1082. doi: 10.1007/s12250-021-00371-1
[13]
Haili Zhang, Hongli Jin, Feihu Yan, Yumeng Song, Jiaxin Dai, Cuicui Jiao, Yujie Bai, Jingxuan Sun, Di Liu, Shen Wang, Mengyao Zhang, Jilong Lu, Jingbo Huang, Pei Huang, Yuanyuan Li, Xianzhu Xia, Hualei Wang, 2023: An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV, Virologica Sinica, 38, 244-256. doi: 10.1016/j.virs.2022.12.006
[14]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[15]
Tielong Chen, Yilan Hu, Quanquan Ding, Jing Yu, Fubing Wang, Fengling Luo, Xiao-Lian Zhang, 2015: Serum ficolin-2 concentrations are significantly changed in patients with hepatitis B virus infection and liver diseases, Virologica Sinica, 30, 249-260. doi: 10.1007/s12250-015-3605-4
[16]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Correction to: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 887-887. doi: 10.1007/s12250-020-00318-y
[17]
Xiaoping Chen, Qunqun Jiang, Zhiyong Ma, Jiaxin Ling, Wenjia Hu, Qian Cao, Pingzheng Mo, Lei Yao, Rongrong Yang, Shicheng Gao, Xien Gui, Wei Hou, Yong Xiong, Jinlin Li, Yongxi Zhang, 2020: Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection, Virologica Sinica, 35, 842-845. doi: 10.1007/s12250-020-00276-5
[18]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8
[19]
Jing-Yu Wang, Tian-Ning Li, Chun-Lei Zhou, Jie Zhao, Meng Wang, Yuan Wang, Yan Jiang, He-Nan Dong, Qian-Ru Qi, Hong Mu, 2022: Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China, Virologica Sinica, 37, 850-859. doi: 10.1016/j.virs.2022.10.009
[20]
Wen-Hua Kong, Rong Zhao, Jun-Bo Zhou, Fang Wang, De-Guang Kong, Jian-Bin Sun, Qiong-Fang Ruan, Man-Qing Liu, 2020: Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity, Virologica Sinica, 35, 752-757. doi: 10.1007/s12250-020-00270-x